EUVIMEDEUVIMED entdecken
Übersichtsarbeit

IDH1/2 mutation detection in gliomas

Hideyuki Arita, Yoshitaka Narita, Akihiko Yoshida, Naoya Hashimoto, Toshiki Yoshimine, Koichi Ichimura

Brain Tumor Pathology · 2015-04 · 32 (2) · 79-89

DOI: 10.1007/s10014-014-0197-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Tumor Pathology, online erschienen am 10.07.2014. Verfasst von Hideyuki Arita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan, h-arita@nsurg.med.osaka-u.ac.jp. Hauptthemen laut MEDLINE: Mutation. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Somatic mutations of isocitrate dehydrogenase 1 and 2 (IDH1/2) are strongly associated with pathological subtypes, genetic profiles, and clinical features in gliomas. The IDH1/2 status is currently regarded as one of the most important molecular markers in gliomas and should be assessed accurately and robustly. However, the methods used for IDH1/2 testing are not fully standardized. The purpose of this paper is to review the clinical significance of IDH1/2 mutations and the methods used for IDH1/2 testing. The optimal method for IDH1/2 testing varies depending on a number of factors, including the purpose, sample types, sample number, or laboratory equipment. It is therefore important to acknowledge the advantages and disadvantages of each method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationEpigenesis, GeneticGenetic Association StudiesGenetic MarkersGenetic TestingGliomaHumansIsocitrate DehydrogenasePrognosisSequence Analysis

Substanzen

Genetic MarkersIDH2 protein, humanIsocitrate DehydrogenaseIDH1 protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan, h-arita@nsurg.med.osaka-u.ac.jp.

Zitieren

APA

Arita, H., Narita, Y., Yoshida, A., Hashimoto, N., Yoshimine, T., & Ichimura, K. (2015). IDH1/2 mutation detection in gliomas. Brain Tumor Pathology, 32(2), 79-89. https://doi.org/10.1007/s10014-014-0197-x

Vancouver

Arita H, Narita Y, Yoshida A, Hashimoto N, Yoshimine T, Ichimura K. IDH1/2 mutation detection in gliomas. Brain Tumor Pathology. 2015;32(2):79-89. doi:10.1007/s10014-014-0197-x

BibTeX
@article{Arita2015,
  author = {Arita, Hideyuki and Narita, Yoshitaka and Yoshida, Akihiko and Hashimoto, Naoya and Yoshimine, Toshiki and Ichimura, Koichi},
  title = {IDH1/2 mutation detection in gliomas},
  journal = {Brain Tumor Pathology},
  year = {2015},
  volume = {32},
  number = {2},
  pages = {79--89},
  doi = {10.1007/s10014-014-0197-x}
}
Kostenlos starten →